Two simple, sensitive, economical and extraction-free spectrophotometric methods have been developed for the determination of ofloxacin (OFX) in pure form and in tablets. The methods are based on the interaction of OFX with two sulphonphthalein dyes, namely, bromothymol blue (method A) and bromophenol blue (method B) in dichloromethane medium to form stable, yellow-colored ion-pair complexes peaking at 410 nm. Under the optimum conditions, OFX could be assayed in the concentration ranges 1.25-20 and 1.0-16 µg mL -1 OFX by methods A and B, respectively, with correlation coefficient of 0.999 in both methods. The apparent molar absorptivity values are calculated to be 1.74×10 4 and 2.18×10 4 , L moL -1 cm -1 , for method A and B, respectively, with corresponding Sandell sensitivity values of 0.021 and 0.017 µg cm -2 . The limits of detection (LOD) and quantification (LOQ) are also reported. The stoichiometry of the reaction was found to be 1:1 in both cases and the conditional stability constants (K f ) of the complexes have also been reported. The intra-day and inter--day variation was assessed. The methods were applied to determine OFX from marked tablet formulations. Statistical analysis proved that the proposed methods were both accurate and precise.
Ofloxacin (OFX), (RS)-7-fluoro-2-methyl-6-(4-methylpiperazine-1-yl)-10-oxo-4-oxa-1-azatricyclo [7. 3.1.0 5, 13 ]trideca-5(13),6,8,11-tetraene-11-carboxylic acid (Figure 1 ), is a fluoroquinolone antibiotic which acts against resistant mutants of bacteria by inhibiting DNA gyrase [1] . OFX possesses two relevant ionizable functional groups: a basic piperazinyl group and a carboxylic group. The carboxylic group and the carbonyl groups are required for antimicrobial activity. Fluoroquinolones also affect trace metal metabolism and are potent inhibitors of some copper-and zinc--dependent enzymes [2] . OFX is official in the United States Pharmacopoeia [3] and the British Pharmacopoeia [4] , which recommend non-aqueous titrimetry [3, 4] and HPLC [3] techniques for its assay in bulk and dosage forms.
A survey of the literature revealed that OFX has been estimated in pharmaceuticals by atomic absorp- Spectrophotometry is characterized by its speed and simplicity, accuracy and inexpensive instrument needed, hence it is an important alternative to other analytical techniques with clear advantages in terms of cost of analysis. Few UV-spectrophotometric me-thods [20] [21] [22] have been reported for determination of OFX in combined dosage forms. The most widely used technique for the assay of OFX has been visible spectrophotometry and methods based on diverse reaction chemistries such as oxidative coupling reaction using Ce(IV)-MBTH [23] , condensation reaction with citric acid-acetic anhydride [24] , complex formation reaction with Fe (III) nitrate nonahydrate [25] , iron (III) chloride in HCl medium [26] , ion pair complex with tropaeolin and supracene violet 3B [27] or with bromophenol blue (BPB), bromothymol blue (BTB) and bromocresol purple (BCP) [28] have been reported for the determination of OFX. Most of the above visible spectrophotometric methods suffer from one or other disadvantage such as use of expensive reagents, use of heating step, poor sensitivity, liquid-liquid extraction step and close pH control as indicated in Table 1 .
In the reported extractive spectrophometric methods for the determination of OFX [27, 28] , the ion-pairs formed at specific pH were extracted into chloroform before measurement. These procedures involve strict pH control besides the cumbersome extraction step. Many a time, incomplete separation may lead to erratic results. In response to the problem resulting from extraction of the ion-pair few articles were published for the analysis of pharmaceutical compounds through ion-pair formation without extraction [29] [30] [31] [32] .
In the present study, we explored the utilization of a simple ion-pair extraction-free technique for the determination of OFX in pure form and in tablets. The present methods employed bromothymol blue (BTB) and bromophenol blue (BPB) as chromogenic agents and the resulting ion pairs are measured directly in dichloromethane. The methods were demonstrated to be more sensitive than the reported extraction methods [27, 28] for OFX and offer the advantages over the existing spectrophotometric methods in terms of simplicity, sensitivity, speed, accuracy and precision.
EXPERIMENTAL DETAILS

Apparatus
All absorbance measurements were made using a Systronics model 106 digital spectrophotometer (Ahmedabad, India) equipped with 1-cm matched quartz cells.
Materials and reagents
All chemicals and reagents used were of analytical-reagent grade. The solvents used were of HPLC-grade. -Pharmaceutical grade OFX certified to be 99.98% pure was received as a gift from Cipla India Ltd., Mumbai, India, and was used as received. Standard OFX solutions were prepared in dichloromethane.
-Two brands of tablets containing OFX, Zenflox--400 (Mankind Pharma Pvt Ltd., New Delhi, India) and Ofloxin-400 (J. B. Chemicals and Pharmaceuticals Ltd, Mumbai, India), used in the investigation were purchased from local commercial sources.
-0.03% Bromothymol blue (BTB, Loba Chemie, Mumbai, India) and 0.05 % bromophenol blue (BPB, Loba Chemie, Mumbai, India) were prepared in dichloromethane (Merck, Mumbai, India).
Construction of calibration curves
Method A Aliquots of 0.25, 0.50, 1.0 and 4.0 mL OFX standard solution in dichloromethane (25 μg mL -1 ) were measured accurately and transferred into a series of 5 mL volumetric flasks. 1 mL of 0.03 % BTB was added to each flask, diluted to the mark with dichloromethane and mixed well. The absorbance of the resulting yellow color chromogen was measured at 410 nm against the reagent blank.
Method B
Aliquots of 0.25, 0.50, 1.0 and 4.0 mL OFX standard solution in dichloromethane (20 μg mL -1 ) were measured accurately and transferred into a series of 5 mL volumetric flasks. 1 mL of 0.05 % BPB was added to each flask, diluted to the mark with dichloromethane and mixed well. The absorbance of the resulting yellow color chromogen was measured at 410 nm against reagent blank.
In both methods, a standard graph was prepared by plotting the increasing absorbance values versus concentration of OFX. The concentration of the unknown was read from the standard graph or computed from the respective regression equation derived using the Beer's law data.
Procedure for the assay of OFX in tablets
Ten tablets were accurately weighed and powdered. A portion equivalent to 25 mg OFX was accurately weighed and transferred into a 50 mL volumetric flask, 30 mL of dichloromethane was added to the flask and the content was shaken thoroughly for 15-20 min to extract the drug into the liquid phase; the volume was finally diluted to the mark with dichloromethane, mixed well and filtered using a Whatman No. 42 filter paper. An aliquot of the filtrate (500 μg mL -1 in OFX) was further diluted to get required concentrations and analysed for OFX following the procedures described for the calibration curve.
Placebo blank analysis
A placebo blank of commonly employed tablet excipients, consisting of talc (10 mg), starch (5 mg), acacia (5 mg), methyl cellulose (10 mg), sodium citrate (5 mg), magnesium stearate (10 mg) and sodium alginate (5 mg) was made and its solution was prepared as described under 'Procedure for tablets', and then analysed using the procedures described above.
Procedure for the determination of OFX in synthetic mixture
To the placebo blank of the composition described above, 20 mg of OFX was added and homogenized, transferred to a 50 mL volumetric flask and the solution was prepared as described under "Procedure for tablets". An aliquot (10 μg mL -1 OFX in method A and 8 µg mL -1 OFX in method B) was then subjected to analysis by the procedures described above after appropriate dilution with dichloromethane. This analysis was performed to study the interference by excipients such as talc, starch, acacia, methyl cellulose, sodium citrate, magnesium stearate and sodium alginate.
Procedure for stoichiometric relationship
Job's method of continuous variations of equimolar solutions was employed: 6.805×10
-5 M each of OFX and BTB (method A) and 5.444×10
-5 M each of OFX and BPB (method B) solutions in dichloromethane were prepared separately. A series of solutions was prepared in which the total volume of OFX and the dye was kept at 5 mL. The drug and reagent were mixed in various complementary proportions (0:5, 1:4, 2:3,…,5:0, inclusive) and completed as directed under the recommended procedures. The absorbance of the resultant ion-pair complex was measured at 410 nm.
RESULTS AND DISCUSSION
OFX is an amino-compound containing a piperazine moiety. Hence, attempts were made to determine it by applying an ion-pair technique in which basic cationic nitrogen in OFX forms an ion-pair with an anionic dye, where a highly yellow colored ion-pair complex is formed. Based on this, two simple methods have been developed utilizing BTB and BPB as chromogenic agents.
Absorption spectra OFX in dichloromethane does not absorb in the visible region and the new broad absorptions in the visible region after the addition of the dyes to the fixed concentrations of the drug indicates the formation of ion pair complex between the drug and dye. Figure 2 shows the absorption spectra of the ion-pair complex, OFX-dye (BTB and BPB) in dichloromethane. The absorption maximum of the ion-pair in dichloromethane is at 410 nm where the absorbance of the reagent blank is insignificant (0.02) in both methods.
Optimization of reaction conditions
Optimum reaction conditions for quantitative determination of ion-pair complexes were established via various preliminary experiments such as choice of organic solvent, concentration of the dye and reaction time.
Choice of organic solvent A number of organic solvents such as dichloromethane, acetone, methanol, dioxane and carbon tetrachloride were examined since OFX is soluble in these solvents. Among these solvents, dichloromethane was preferred as the most suitable solvent because in this medium, the reagent blank gave negligible blank absorbance and the formed ion-pair complex was found to exhibit higher sensitivity and stability. In other solvents, the reagent blank yielded high absorbance values.
Effect of dye concentration
The influence of the concentration of BTB and BPB on the intensity of the color developed at the selected wavelength and constant drug concentration was studied using different amounts (0.25-3.0 mL) of 0.03% of BTB in method A and (0.25-2.0 mL) of 0.05% BPB in method B. As shown in Figure 3 , the constant absorbance readings were obtained between (0.5-3.0 mL) of 0.03% of BTB in method A and (0.5-2.0 mL) of 0.05% BPB in method B. Hence, 1 mL of each 0.03% BTB and 0.05% BPB was used for methods A and B, respectively.
Effect of reaction time
The optimum reaction time for the development of color at ambient temperature (25±2 °C) was studied and it was found that complete color development was instantaneous in both methods. The formed color was stable for at least 60 min in both cases (Figure 4 ). 
Stoichiometric ratio
In order to establish the molar ratio between OFX and dyes, Job's method of continuous variations was applied. In both cases, the plot reached a maximum value at a mole fraction of 0.5 which indicated the formation of 1:1 (OFX:Dye) complex ( Figure 5 ) between positive protonated OFX + and BTB -or BPB -as shown in Scheme 1. In OFX, the nitrogen atom bonded to electron donating methyl group in the piperazine ring is the most vulnerable one for protonation [33] .
Conditional stability constants (K f ) of the ion-pair complexes
The conditional stability constants (K f ) of the ion--pair complexes for OFX were calculated from the continuous variation data using the following equation 
Method validation procedures
The proposed methods have been validated for linearity, sensitivity, precision, accuracy, selectivity and recovery. Table  2 . Sensitivity parameters, such as apparent molar absorptivity and Sandell's sensitivity values, the limits of detection and quantification are calculated as per the current ICH guidelines [35] as compiled in Table 2 speak of the excellent sensitivity of the proposed methods. The limits of detection (LOD) and quantification (LOQ) were calculated according to the same guidelines using the formulae: LOD = 3.3σ/s and LOQ = 10σ/s where σ is the standard deviation of five reagent blank determinations and s is the slope of the calibration curve.
Precision and accuracy
In order to evaluate the precision of the proposed methods, solutions containing three different concentrations of the OFX were prepared and analyzed in seven replicates. The analytical results obtained from this investigation are summarized in Tab Found Taken %RE= ×100 Taken
The assay procedure was repeated seven times, and percentage relative standard deviation values were obtained within the same day to evaluate repeatability (intra-day precision) and over five different days to evaluate intermediate precision (inter-day precision).
Selectivity
The proposed methods were tested for selectivity by placebo blank and synthetic mixture analyses. The placebo blank solution prepared as described earlier was subjected to analysis according to the recommended procedures. The resulting absorbance readings for both methods were same as the reagent blank, inferring no interference from placebo. Table 3 . Evaluation of intra-day and inter-day accuracy and precision Method OFX taken µg mL -1 Intra-day accuracy and precision (n = 7) Inter-day accuracy and precision (n = 7)
OFX found±CL, μg mL A separate experiment was performed with the synthetic mixture. The analysis of synthetic mixture solution prepared above yielded percent recoveries which ranged of 98.45-103.6 with standard deviation of 0.91-1.13 in all the cases. The results of this study are presented in Table 4 indicating that the inactive ingredients did not interfere in the assay. These results further demonstrate the accuracy as well as the precision of the proposed methods.
Application to formulations
In order to evaluate the analytical applicability of the proposed methods to the quantification of OFX in commercial tablets, the results obtained by the proposed methods were compared to those of the reference method [4] by applying Student's t-test for accuracy and F-test for precision. The reference method involved the titration of OFX in anhydrous acetic acid with acetous perchloric acid to a potentiometric end point detection. The results (Table 5) show that the Student's t-and F-values at 95 % confidence level are less than the tabulated values, which confirmed that there is good agreement between the results obtained by the proposed methods and the reference method with respect to accuracy and precision.
Recovery studies
The accuracy and validity of the proposed methods were further ascertained by performing recovery studies. Pre-analysed tablet powder was spiked with pure OFX at three concentration levels (50, 100 and 150% of that in tablet powder) and the total was found by the proposed methods. In all cases, the added OFX recovery percentage values ranged of 98.60--102.9% with standard deviation of 1.07-1.21 (Table  6 ) indicating that the recovery was good, and that the co-formulated substance did not interfere in the determination. 
CONCLUSIONS
Two simple, fast, extraction-free spectrophotometric methods for the determination of OFX in pure form and in tablets were developed and validated as per as the current ICH guidelines. Compared with most of the existing methods for OFX, the present methods are very simple, rapid and cost effective. Of the non--chromatographic methods, the method based on atomic absorption spectrophotometry [5] requires an expensive instrument. Although chemiluminescence methods [6] [7] [8] are sensitive, they require expensive experimental set up. The differential pulse voltammetric method [9] also requires strict pH control and is less sensitive (linear range 10-100 μg mL -1 ). The chromatographic methods [10] [11] [12] [13] [14] , no doubt, are sensitive and selective; however require complex and expensive equipment, provision for use and disposal of large quantities solvents, labour-intensive sample preparation procedure and personnel skilled in chromatographic techniques.
The reported visible spectrophotometric methods based on oxidative-coupling reaction [23] uses expensive reagent and the reaction product is less stable. The method based on condensation reaction [24] involves boiling step for 20 min. Complexation reaction procedures suffer from strict pH control [25] less sensitive (linear range 20-160 μg mL -1 ) [26] . Extractive-spectrophotometric methods [27, 28] based on ion-pair complex formation reactions, though sensitive and selective, are devoid of simplicity since critical pH control and liquid-liquid extraction step are involved.
In contrast to the above published visible spectrophotometric methods [23] [24] [25] [26] [27] [28] , the proposed extraction free spectrophotometric methods based on ion--pair complex formation reactions require only dyes as reagents which are cheaper and readily available, can be applied at ambient temperature, color development is instantaneous and neither involves strict pH adjustment nor complicated extraction step. The proposed methods have wide linear dynamic ranges and are most sensitive than most of other published methods. They can be useful in quality control and routine analysis of OFX in pharmaceuticals since both methods are simple, accurate and free from common additives and excipients that might be found in commercial preparations. . Takođe su određeni limiti detekcije i kvantifikacije. U oba slučaja reakcija se odvija u stehiometrijskom odnosu 1:1. Izračunate su konstante stabilnosti kompleksa i varijacije u za određene vremeske periode u toku dana i za više dana. Statistička analiza je pokazala da su predložene motode tačne i precizne i da se mogu primenjivati za određivanje OFX u tabletama.
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